Response and Duration of Serum Anti-SARS-CoV-2 Antibodies Induced by the Third Dose of an Inactivated Vaccine: A Prospective Longitudinal Cohort Study at 21 Serial Time Points over 641 Days
Description
Given the prevalence of low-pathogenic but highly infectious Omicron variants, a cohort study was conducted to assess the response and duration of novel coronavirus-inactivated vaccine-induced antibodies one year after the third dose (day 641). Blood
